Add Company
Join Now

SIWA Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SIWA Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • SIWA Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • SIWA Therapeutics has 11 Employees.(i)
  • SIWA Therapeutics grew their employee count by 0% last year.

SIWA Therapeutics's People

NameTitleEmail/Phone
1
CEO & Chief Scientific OfficerReveal Email/Phone
2
Chief Administrative OfficerReveal Email/Phone
3
ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is SIWA Therapeutics?

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells. Our current therapeutic focus is on certain rare and fast track diseases, including cancer metastasis and muscle wasting diseases, such as muscular dystrophy. Beyond these indications, senescent cells are causally implicated in a wide variety of diseases including: neurodegenerative diseases; autoimmune conditions, and infectious diseases. SIWA is currently optimizing its lead antibody, SIWA 318, and in parallel, seeking partnerships to advance SIWA 318 and other related technologies to broaden and accelerate its development pipeline.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M11-8%N/A
#2
$1M11N/AN/A
#3
$1M11N/AN/A
#4
$0.9M11N/AN/A
#5
$1M11N/AN/A